Your browser doesn't support javascript.
loading
Real-world clinical outcomes in patients with relapsed and refractory multiple myeloma receiving VTD-PACE treatment in the era of monoclonal antibodies.
Kikuchi, Taku; Tsukada, Nobuhiro; Kunisada, Kodai; Nomura-Yogo, Moe; Oda, Yuki; Sato, Kota; Takei, Tomomi; Ogura, Mizuki; Abe, Yu; Suzuki, Kenshi; Ishida, Tadao.
Affiliation
  • Kikuchi T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan. taku_k_1123@mac.com.
  • Tsukada N; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Kunisada K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Nomura-Yogo M; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Oda Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Sato K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Takei T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Ogura M; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Abe Y; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center, 4-chome-1-22 Hiroo, Shibuya-Ku, Tokyo, 150-8935, Japan.
Ann Hematol ; 102(12): 3489-3497, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37668787
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2023 Type: Article Affiliation country: Japan